BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10807142)

  • 1. A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, the Netherlands.
    de Rijke JM; Schouten LJ; Schreutelkamp JL; Jochem I; Verbeek AL
    J Med Screen; 2000; 7(1):19-23. PubMed ID: 10807142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiological review of interval cancers in an Australian mammographic screening programme. Radiology Quality Assurance Group of BreastScreen Victoria.
    Amos AF; Kavanagh AM; Cawson J
    J Med Screen; 2000; 7(4):184-9. PubMed ID: 11202584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program.
    Hofvind S; Skaane P; Vitak B; Wang H; Thoresen S; Eriksen L; Bjørndal H; Braaten A; Bjurstam N
    Radiology; 2005 Nov; 237(2):437-43. PubMed ID: 16244251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
    Otten JD; Karssemeijer N; Hendriks JH; Groenewoud JH; Fracheboud J; Verbeek AL; de Koning HJ; Holland R
    J Natl Cancer Inst; 2005 May; 97(10):748-54. PubMed ID: 15900044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
    Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
    Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiologic analysis of interval cancers in the screening program called Florence Woman Project].
    Morrone D; Giorgi D; Ciatto S; Ceresatto E; Catarzi S; Roselli Del Turco R
    Radiol Med; 2000 Nov; 100(5):321-5. PubMed ID: 11213408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters.
    Duijm LE; Groenewoud JH; Fracheboud J; de Koning HJ
    J Natl Cancer Inst; 2007 Aug; 99(15):1162-70. PubMed ID: 17652282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the detection of cancer in the screening of mammograms.
    Laming D; Warren R
    J Med Screen; 2000; 7(1):24-30. PubMed ID: 10807143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval cancer peer review in East Anglia: implications for monitoring doctors as well as the NHS breast screening programme.
    Britton PD; McCann J; O'Driscoll D; Hunnam G; Warren RM
    Clin Radiol; 2001 Jan; 56(1):44-9. PubMed ID: 11162697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assessment of the mammographic screening programme in the Azienda Sanitaria locale Provincia Milano 1 -- analysis of interval cancers and discussion of possible causes of diagnostic error.
    Burani R; Caimi F; Maggioni C; Marinoni G; Pellizzoni R; Pirola ME; Villa R; Ciatto S
    Radiol Med; 2005 Mar; 109(3):260-7. PubMed ID: 15775895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of additional double reading of mammograms by radiographers: effects on a biennial screening programme outcome.
    Duijm LE; Groenewoud JH; Fracheboud J; van Ineveld BM; Roumen RM; de Koning HJ
    Eur J Cancer; 2008 Jun; 44(9):1223-8. PubMed ID: 18400488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinded double reading yields a higher programme sensitivity than non-blinded double reading at digital screening mammography: a prospected population based study in the south of The Netherlands.
    Klompenhouwer EG; Voogd AC; den Heeten GJ; Strobbe LJ; de Haan AF; Wauters CA; Broeders MJ; Duijm LE
    Eur J Cancer; 2015 Feb; 51(3):391-9. PubMed ID: 25573788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing interval cancers: time well spent?
    Gower-Thomas K; Fielder HM; Branston L; Greening S; Beer H; Rogers C
    Clin Radiol; 2002 May; 57(5):384-8. PubMed ID: 12014936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening mammograms by community radiologists: variability in false-positive rates.
    Elmore JG; Miglioretti DL; Reisch LM; Barton MB; Kreuter W; Christiansen CL; Fletcher SW
    J Natl Cancer Inst; 2002 Sep; 94(18):1373-80. PubMed ID: 12237283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of mammography screening in the Veneto Region. Evaluation of four programs at a local health unit level--analysis of the frequency and diagnostic pattern of interval cancers.
    Vettorazzi M; Stocco C; Chirico A; Recanatini S; Saccon S; Mariotto R; Cinquetti S; Moretto T; Sartori P; Stomeo A; Ciatto S
    Tumori; 2006; 92(1):1-5. PubMed ID: 16683376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population-based study.
    Setz-Pels W; Duijm LE; Groenewoud JH; Voogd AC; Jansen FH; Hooijen MJ; Louwman MW
    Radiology; 2011 Aug; 260(2):357-63. PubMed ID: 21474705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of audits in breast cancer screening quality assurance programmes.
    Geertse TD; Holland R; Timmers JM; Paap E; Pijnappel RM; Broeders MJ; den Heeten GJ
    Eur Radiol; 2015 Nov; 25(11):3338-47. PubMed ID: 25903711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observer variability in cancer detection during routine repeat (incident) mammographic screening in a study of two versus one view mammography.
    Blanks RG; Wallis MG; Given-Wilson RM
    J Med Screen; 1999; 6(3):152-8. PubMed ID: 10572847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers.
    van Dijck JA; Verbeek AL; Hendriks JH; Holland R
    Cancer; 1993 Sep; 72(6):1933-8. PubMed ID: 8364871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.